This study is investigating Type 2 Diabetes Mellitus, a condition where the body does not properly use insulin, leading to high blood sugar levels. The study will use two medications: semaglutide, which helps control blood sugar by affecting how the body produces insulin and slows digestion, and dapagliflozin, which helps remove excess sugar from the body through urine. The purpose of the study is to understand how these two medications work in the body when taken together in one tablet compared to when they are taken separately.
During the study, participants will receive different combinations of semaglutide and dapagliflozin in tablet form. Some participants will take the medications separately, while others will take them combined in a single tablet. The tablets will be taken by mouth and will contain varying doses of the medications. The study will measure how the body absorbs and processes these medications by taking blood samples at specific times to check the levels of semaglutide and dapagliflozin in the blood.
The researchers will compare the concentration of each medication in the blood when taken separately versus when taken together to determine if the medications affect each other’s activity in the body. This information will help understand whether combining both medications in one tablet is as effective as taking them separately. The study involves healthy participants who will be monitored throughout the treatment period to collect the necessary data about how these medications work in the body.
Germany 
